QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Scopus BioPharma (SCPS) Competitors

$0.0025
0.00 (0.00%)
(As of 04/15/2024 ET)

SCPS vs. STAB, NOVN, NOVNQ, IGNY, HGEN, VRAYQ, AHPI, PKBO, ONCSQ, and CNTX

Should you be buying Scopus BioPharma stock or one of its competitors? The main competitors of Scopus BioPharma include Statera Biopharma (STAB), Novan (NOVN), NVN Liquidation (NOVNQ), Ignyte Acquisition (IGNY), Humanigen (HGEN), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Peak Bio (PKBO), OncoSec Medical (ONCSQ), and Context Therapeutics (CNTX). These companies are all part of the "medical" sector.

Scopus BioPharma vs.

Scopus BioPharma (NASDAQ:SCPS) and Statera Biopharma (NASDAQ:STAB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, community ranking, risk and dividends.

Scopus BioPharma has higher earnings, but lower revenue than Statera Biopharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scopus BioPharmaN/AN/A-$11.61MN/AN/A
Statera Biopharma$1.49M0.02-$101.85MN/AN/A

Scopus BioPharma received 2 more outperform votes than Statera Biopharma when rated by MarketBeat users.

CompanyUnderperformOutperform
Scopus BioPharmaOutperform Votes
2
100.00%
Underperform Votes
No Votes
Statera BiopharmaN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scopus BioPharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Statera Biopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
Scopus BioPharmaN/A N/A N/A
Statera Biopharma N/A N/A N/A

Scopus BioPharma has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, Statera Biopharma has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500.

In the previous week, Statera Biopharma had 1 more articles in the media than Scopus BioPharma. MarketBeat recorded 1 mentions for Statera Biopharma and 0 mentions for Scopus BioPharma. Statera Biopharma's average media sentiment score of 0.74 beat Scopus BioPharma's score of 0.00 indicating that Statera Biopharma is being referred to more favorably in the news media.

Company Overall Sentiment
Scopus BioPharma Neutral
Statera Biopharma Positive

Summary

Scopus BioPharma and Statera Biopharma tied by winning 3 of the 6 factors compared between the two stocks.

Get Scopus BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SCPS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCPS vs. The Competition

MetricScopus BioPharmaPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$105,000.00$6.49B$4.72B$7.48B
Dividend YieldN/A3.10%5.47%3.96%
P/E RatioN/A10.53217.8416.12
Price / SalesN/A316.602,535.6987.66
Price / CashN/A20.4433.2528.19
Price / Book-0.015.504.664.27
Net Income-$11.61M$141.84M$100.33M$210.80M
7 Day PerformanceN/A-6.31%-4.94%-5.11%
1 Month PerformanceN/A-5.69%-3.63%-2.63%
1 Year PerformanceN/A0.95%12.17%6.35%

Scopus BioPharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STAB
Statera Biopharma
0 of 5 stars
$0.00
flat
N/A-96.4%$33,000.00$1.49M0.0046Negative News
NOVN
Novan
0 of 5 stars
$0.00
flat
N/A-99.9%$22,000.00$24.71M0.0090Analyst Report
News Coverage
NOVNQ
NVN Liquidation
0 of 5 stars
$0.00
flat
N/AN/A$22,000.00$23.68M0.0090
IGNY
Ignyte Acquisition
0 of 5 stars
$0.01
flat
N/AN/A$38,000.00N/A0.00N/A
HGEN
Humanigen
0 of 5 stars
N/AN/AN/A$24,000.00$1.70M0.006
VRAYQ
ViewRay
0 of 5 stars
N/AN/AN/A$20,000.00$102.21M0.00295
AHPI
Allied Healthcare Products
0 of 5 stars
N/AN/AN/A$16,000.00$27.05M0.00189
PKBO
Peak Bio
0 of 5 stars
$0.01
flat
N/AN/A$118,000.00$610,000.000.0021High Trading Volume
ONCSQ
OncoSec Medical
0 of 5 stars
$0.00
flat
N/AN/A$1,000.00N/A0.0040
CNTX
Context Therapeutics
2.774 of 5 stars
$1.31
+0.8%
$4.00
+205.3%
+141.7%$0.00N/A-0.875

Related Companies and Tools

This page (NASDAQ:SCPS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners